Oncolytics Biotech Inc T.ONC

Increased buying in ONC by Institutions

[askretka]

13 Feb 2022 Oncolytics Biotech Inc. (NASDAQ:ONCY) was the target of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 293,900 shares, a growth of 124.9% from the January 15th total of 130,700 shares. Based on an average daily volume of 415,600 shares, the short-interest ratio is currently 0.7 days. Approximately 0.5% of the companys stock are short sold. Several institutional investors have recently modified their holdings of ONCY. Renaissance Technologies LLC grew its position in shares of Oncolytics Biotech by 812.6% in the 3rd quarter. Renaissance Technologies LLC now owns 209,900 shares of the companys stock worth $439,000 after buying an additional 186,900 shares during the last quarter. Advisor Resource Council purchased a new position in shares of Oncolytics Biotech in the 2nd quarter worth approximately $280,000. JPMorgan Chase & Co. grew its position in shares of Oncolytics Biotech by 167.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 150,673 shares of the companys stock worth $919,000 after buying an additional 94,390 shares during the last quarter. Morgan Stanley grew its position in shares of Oncolytics Biotech by 79.7% in the 3rd quarter. Morgan Stanley now owns 83,152 shares of the companys stock worth $174,000 after buying an additional 36,874 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of Oncolytics Biotech in the 2nd quarter worth approximately $98,000. 1.90% of the stock is currently owned by hedge funds and other institutional investors. --------------------------------------------------- Looks like things are starting to get interesting. Cheers!!

[westcoast1000]

Askretka's post on institutional ownership is excellent news!  It shows the burned, negative and nervous (per Yahoo Finance) that smart money investors see value here.